![]() Legend Biotech Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
| ![]() Rein Therapeutics Rein Therapeutics (formerly known as Aileron Therapeutics) is a clinical-stage biopharmaceutical company that develops medicines targeting undruggable cancer sites using its proprietary platform of stabilized cell-permeating peptides. | ![]() Ikena Oncology Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment. | ||
Founding Date | Founding Date 2016 | Founding Date 2014 | Founding Date 2005 | Founding Date 2016 |
Type | Type Private | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Newcastle upon Tyne, GB HQ Stockton On Tees, GB | Locations Somerset, US HQ Ghent, BE Nanjing, CN Hong Kong, HK Dublin, IE Piscataway, US | Locations Watertown, US HQ Boston, US | Locations Boston, US HQ |
Employees | Employees 15 | Employees 2,90012% increase | Employees 838% decrease | Employees 5052% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.4 b | Valuation ($) 90.2 m | Valuation ($) 82.5 m |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $800k (FY, 2025) |
Net income | Net income N/A | Net income ($296.8m) (FY, 2025) | Net income ($49.9m) (FY, 2025) | Net income ($45.3m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised $ 150.5m | Total funding raised $ 112m | Total funding raised $ 49m |

Legend Biotech is a biopharmaceutical company engaged in the discovery and development of cell therapies for oncology and other indications.
View company
Rein Therapeutics (formerly known as Aileron Therapeutics) is a clinical-stage biopharmaceutical company that develops medicines targeting undruggable cancer sites using its proprietary platform of stabilized cell-permeating peptides.
View company
Ikena Oncology (formerly Kyn Therapeutics) is a biotechnology company that discovers and develops biomarker-driven therapies for cancer treatment.
View company